ClinicalTrials.Veeva

Menu

Utility of Renal Biomarkers in Cirrhosis

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

Cirrhosis
Ascitis

Study type

Observational

Funder types

Other

Identifiers

NCT01217983
PRD 2010-I-15 (Other Grant/Funding Number)
10-056 Med 10-019

Details and patient eligibility

About

Evaluation of kidney function is critical in cirrhotic patients as there is a clear relationship between renal failure and prognosis. The investigators hypothesized that in this population new biomarkers of renal function could help in early detection of acute renal failure and in discrimination between renal and pre-renal causes. Finally the investigators hypothesized that such biomarkers could predict short-term outcome in this population.

Enrollment

105 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Known or suspected cirrhosis
  • Suspected ascitis
  • Informed consent signed

Exclusion criteria

  • Proven multifocal hepatocellular carcinoma
  • Acute gastric hemorrhage (active or < 2 weeks)
  • Known end-stage renal disease or on dialysis before admission
  • Recipients of kidney or liver transplants
  • Transferred from another institution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems